No abstract

No abstract

No abstract

Résumé : La psychose secondaire à l'épilepsie comprend un groupe de troubles qui sont étroitement associés aux crises d'épilepsie. Il s'agit notamment de la psychose inter-ictale, de la psychose alternative et de la psychose post-ictale. Cette dernière est une complication rare de l’épilepsie, caractérisée par des symptômes psychotiques réversibles après des rafales de crises. Le but de cet article de synthèse est de mettre en évidence les aspects cliniques et neuroradiologiques de la psychose post-ictale qui peuvent aider à l'évaluation et la gestion du trouble épileptique associé, et d'identifier les circonstances dans lesquelles une intervention thérapeutique opportune des neurologues permettrait d’éviter ou réduire le risque de survenue d'un épisode psychotique Abstract: Psychosis secondary to epilepsy includes a group of disorders that are associated with epileptic seizures. They include interictal psychosis, alternative psychosis and postictal psychosis. The latter is a rare complication of epilepsy characterized by reversible psychotic symptoms after burst of epileptic seizures. The aim of this review article is to highlight clinical and neuroradiological aspects of postictal psychosis that may aid in the assessment and management of the associated seizure disorder and pinpoint the circumstances in which a timely therapeutic intervention of neurologists could avoid or reduce the chances of the occurrence of a psychotic episode

Parkinson’s disease can lead to disability and reduce the quality of life of its patients. The purpose of this study is to evaluate the quality of life of a group of people with Parkinson’s disease. The clinical and progressive characteristics of the disease, its motor and neuropsychological impact were evaluated in each Parkinsonian subject included in the study. A quality of life assessment was performed and collected from 60 Parkinsonian patients followed and hospitalized at Hassan II University Hospital in Fez. Different instruments were used, the Hoenh and Yahr scale and the Parkinson’s disease questionnaire (PDQ-39) UPDRS engine, MMS, clinical fact sheet. According to our results, through the different tests and scale of evaluation, we observed an impaired quality of life in the areas of physical discomfort, cognitive disorder, activity of daily living, mobility, and emotional well-being, especially in patients with duration of evolution more than 5 years. There was no significant difference between the two sexes. In addition, the severity of the disease tended to give the impression of an impaired quality of life with respect to the dimensions of activities of daily living and cognition, which is relevant to improving the quality of life patient life and clinical interventions.